• LY294002 for PI3K/Akt/mTOR Assay Design

  2026-08-20

  LY294002 provides a reversible, cell-permeable way to interrogate class I PI3K signaling across cancer, autophagy, and inflammatory cell models. This guide translates the ajugol gouty-arthritis study into practical assay designs, controls, dose planning, and troubleshooting strategies.

• Bazedoxifene Blocks Hemozoin Formation in Malaria

  2026-08-20

  Sudhakar and colleagues show that bazedoxifene, a third-generation selective estrogen receptor modulator, inhibits susceptible and drug-resistant Plasmodium falciparum and reduces Plasmodium berghei infection in female mice. The study links activity to early ring-stage vulnerability and impaired hemozoin formation, supporting drug repurposing while highlighting sex-specific differences in in vivo efficacy.

• TH287 Radiosensitizes Castration-Resistant Prostate Cancer

  2026-08-19

  The reference study shows that TH287 increases the response of PC-3 and DU-145 castration-resistant prostate cancer cells to ionizing radiation, with the strongest effect when radiation follows drug exposure by 12 hours. Its combination of viability, apoptosis, protein-expression, and cell-cycle analyses supports MTH1 inhibition as a timing-sensitive radiosensitization strategy, while the in vitro design limits direct clinical extrapolation.

• Tamoxifen B5965: Reliable Cell Assay Workflows

  2026-08-19

  Learn how Tamoxifen (SKU B5965) can support reproducible viability, proliferation, cytotoxicity, and CreER-mediated gene knockout workflows. This scenario-based guide covers mechanism-aware assay design, solubility, controls, interpretation, and practical vendor selection.

• T7 RNA Polymerase for RNA Assay Workflows

  2026-08-18

  T7 RNA Polymerase enables defined, promoter-directed RNA production from linearized plasmids and PCR templates for probes, translation studies, RNAi, and vaccine research. This guide connects practical transcription control with the DDX21–NAT10 findings reported in colorectal cancer, while highlighting assay boundaries and troubleshooting strategies.

• Gramine for Ferroptosis and TNBC Research

  2026-08-18

  Gramine is a research-grade ferroptosis inducer for connecting triple-negative breast cancer cell viability with CUL3–MTDH signaling. This practical guide covers solvent handling, dose-response design, target-engagement assays, rescue experiments, and troubleshooting for reproducible cancer biology research.

• BHQ: Selective SERCA Inhibitor for Calcium Research

  2026-08-17

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) is a selective SERCA inhibitor used to study endoplasmic reticulum calcium storage, calcium signaling, and cellular stress. A 2025 in vivo study linked BHQ-mediated SERCA inhibition with enhanced hematopoietic stem cell mobilization through the CaMKII-STAT3-CXCR4 pathway.

• TH287 Radiosensitizes CRPC Cells to Ionizing Radiation

  2026-08-17

  The 2026 reference study identifies a schedule-dependent radiosensitizing effect of TH287 in PC-3 and DU-145 castration-resistant prostate cancer cells. Its central finding is that administering ionizing radiation 12 hours after MTH1 inhibition produced stronger survival suppression, apoptosis, and cell-cycle disruption than later radiation schedules.

• AMG 9810: TRPV1 Antagonist Workflow Guide

  2026-08-16

  Build cleaner TRPV1 experiments with AMG 9810, from capsaicin-evoked calcium imaging to CGRP secretion assays. This guide combines practical dosing, solvent controls, metabolic-stress safeguards, and troubleshooting for pain mechanism research.

• Benzyl Quinolone Carboxylic Acid (BQCA) Workflow

  2026-08-15

  Benzyl Quinolone Carboxylic Acid (BQCA) offers a selective way to amplify acetylcholine-driven M1 receptor signaling without relying on broad muscarinic activation. This workflow connects concentration–response assays, BRET coupling studies, neuronal readouts, and troubleshooting strategies for cognitive function modulation and Alzheimer’s disease research.

• Lipo3K Transfection Reagent for Resistance Studies

  2026-08-14

  Use Lipo3K Transfection Reagent to build reproducible DNA, siRNA, mRNA, and co-transfection workflows in adherent, suspension, and difficult-to-transfect cells. Its low-toxicity profile and plasmid-focused Lipo3K-A enhancer are especially useful for testing transporter biology in paclitaxel-resistant breast cancer models.

• β-Elemene: Applied 3T3-L1 Research Workflows

  2026-08-14

  Build a reproducible β-Elemene workflow for adipogenesis, insulin-resistance, and AMPK studies, while preserving clear boundaries between metabolic evidence and neuroprotective or anticancer hypotheses. The guide combines the published 3T3-L1 model with practical dosing, assay-selection, solubility, and troubleshooting strategies.

• MK-8745: Translating Aurora A Biology to Oncology

  2026-08-13

  A translational perspective on how MK-8745, a potent and selective Aurora A inhibitor, can connect mitotic biology with cancer-model strategy. The article integrates recent retinoblastoma evidence, practical assay design, xenograft interpretation, and the limitations that matter when moving from target validation to therapeutic hypotheses.

• N1-Methylpseudouridine: A Translational Strategy

  2026-08-13

  A mechanistic and strategic guide to using N1-Methylpseudouridine for more reliable mRNA translation studies, with lessons from PCMT1-driven ovarian cancer metastasis research.

• Injectable GelMA/QCS/Ca2+ Adhesive for Hemostasis

  2026-08-12

  The reference study develops a blue-light-triggered GelMA/QCS/Ca2+ double-network adhesive for rapid control of non-compressible bleeding and bacterial wound protection. Its multi-model evaluation suggests that combining photochemical sealing, tissue adhesion, and chitosan-derived antibacterial activity may address limitations of single-function hemostatic materials.

15786 records 1/1053 page Next 12345 下5页 Last page